<p>A) Cytokine production from the splenocytes of 4 mice in the designated groups 3 weeks after last immunization. Single cell suspensions were cultured in duplicate in the presence of recombinant CPA/CPB or freeze-thawed recombinant <i>L. tarentolae</i>. Culture supernatants were assayed for IFN-γ, IL-4, IL-2 and TNF-α production by ELISA. Each bar represents the Mean±SD of 4 mice per group. B) Antigen specific antibody responses against <i>L. tarentolae CPA/CPB/EGFP</i> and SGH before parasite challenge. Data were generated as Mean±SD for sera of individual mice within their respective vaccination group (n = 8–10). The asterisk indicates the significant difference between values at the indicated time points as determined by Mann Whitney U...
<p>Ten 6-week-old BALB/c mice received 5×10<sup>4</sup> PFU MVTT1, MVTT2 or MVTT3 by intramuscular r...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>Mice were vaccinated s.c. three times <u>at 3 week</u> intervals with lipid core peptides (LCP), ...
<p>Ten days after the last vaccination and 3 months after challenge infection spleens were collected...
<p>Panel A, antibody titers of mice primed with Construct 33-I and boosted with MSP1-42; and antibod...
<p>C57BL/6 mice (3 mice/group) were treated i.n. with <i>C. pneumoniae</i> (1×10<sup>6</sup> IFU/mou...
<p>The humoral and cellular response against soluble <i>Leishmania</i> antigens (SLA) was determined...
<p>Mice were bled after two vaccinations before challenge and 5 weeks after challenge. Sera were obt...
<p>IFN-γ (panel A), IL-10 (panel B), IFNγ/IL-10 ratio (panel C), IL-2 (panel D) and nitrite (NO<sub>...
<p>Ten days, short-term protection (STP), and twelve weeks, long-term protection (LTP) after final b...
<p>One week following the last booster, spleen cells of mice (n = 6) immunized with antigen-free PBS...
<p>For (A) and (B), SEVs (5 μg) and sham (PBS) were injected intramuscularly to mice at weekly inter...
<p>Two weeks after the last booster, spleen cells of mice (n = 5) in each group were stimulated for ...
<p><sup>a</sup> Number of IFNγ secreting cells/10<sup>6</sup> splenocytes (splenocytes were removed ...
<p>Splenocytes isolated from mice vaccinated orally 21 days before with strains V674pF1 (10<sup>8</s...
<p>Ten 6-week-old BALB/c mice received 5×10<sup>4</sup> PFU MVTT1, MVTT2 or MVTT3 by intramuscular r...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>Mice were vaccinated s.c. three times <u>at 3 week</u> intervals with lipid core peptides (LCP), ...
<p>Ten days after the last vaccination and 3 months after challenge infection spleens were collected...
<p>Panel A, antibody titers of mice primed with Construct 33-I and boosted with MSP1-42; and antibod...
<p>C57BL/6 mice (3 mice/group) were treated i.n. with <i>C. pneumoniae</i> (1×10<sup>6</sup> IFU/mou...
<p>The humoral and cellular response against soluble <i>Leishmania</i> antigens (SLA) was determined...
<p>Mice were bled after two vaccinations before challenge and 5 weeks after challenge. Sera were obt...
<p>IFN-γ (panel A), IL-10 (panel B), IFNγ/IL-10 ratio (panel C), IL-2 (panel D) and nitrite (NO<sub>...
<p>Ten days, short-term protection (STP), and twelve weeks, long-term protection (LTP) after final b...
<p>One week following the last booster, spleen cells of mice (n = 6) immunized with antigen-free PBS...
<p>For (A) and (B), SEVs (5 μg) and sham (PBS) were injected intramuscularly to mice at weekly inter...
<p>Two weeks after the last booster, spleen cells of mice (n = 5) in each group were stimulated for ...
<p><sup>a</sup> Number of IFNγ secreting cells/10<sup>6</sup> splenocytes (splenocytes were removed ...
<p>Splenocytes isolated from mice vaccinated orally 21 days before with strains V674pF1 (10<sup>8</s...
<p>Ten 6-week-old BALB/c mice received 5×10<sup>4</sup> PFU MVTT1, MVTT2 or MVTT3 by intramuscular r...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>Mice were vaccinated s.c. three times <u>at 3 week</u> intervals with lipid core peptides (LCP), ...